The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 27, 2025

Filed:

Feb. 10, 2023
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

David V. Schaffer, Danville, CA (US);

Leah C. Byrne, San Francisco, CA (US);

Timothy P. Day, Berkeley, CA (US);

John G. Flannery, Berkeley, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/861 (2006.01); A61K 9/00 (2006.01); A61K 35/761 (2015.01); A61K 48/00 (2006.01); A61P 27/02 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/075 (2006.01); C12N 9/22 (2006.01); C12N 15/10 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); C12N 15/86 (2006.01); C12N 15/90 (2006.01);
U.S. Cl.
CPC ...
A61K 35/761 (2013.01); A61K 9/0048 (2013.01); A61K 48/0041 (2013.01); A61K 48/0075 (2013.01); A61P 27/02 (2018.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/075 (2013.01); C12N 9/22 (2013.01); C12N 15/1082 (2013.01); C12N 15/11 (2013.01); C12N 15/113 (2013.01); C12N 15/86 (2013.01); C12N 15/902 (2013.01); C12N 2310/20 (2017.05); C12N 2750/14122 (2013.01); C12N 2750/14142 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14145 (2013.01); C12N 2750/14171 (2013.01); C12N 2800/80 (2013.01);
Abstract

The present disclosure provides recombinant adeno-associated virus (AAV) virions with altered capsid protein, where the recombinant AAV (rAAV) virions exhibit greater ability to cross barriers between intravitreal fluid and retinal cells, and thus greater infectivity of a retinal cell compared to wild-type AAV, and where the rAAV virions comprise a heterologous nucleic acid. The present disclosure provides methods of delivering a gene product to a retinal cell in an individual.


Find Patent Forward Citations

Loading…